Lecanemab in Early Alzheimer’s Disease
2022 · New England Journal of Medicine · 4,790 citations
https://doi.org/10.1056/nejmoa2212948
D
David Watson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
192
Papers
15.5K
Citations
37
h-index
80
i10-index
David Watson is an academic researcher from University of Nottingham. The author has contributed to research in topics: Mental Health Research Topics & Pregnancy and preeclampsia studies & Birth, Development, and Health. The author has an h-index of 37, co-authored 164 publications.
Papers by this author
worksMeasurement of social-evaluative anxiety.
1969 · Journal of Consulting and Clinical Psychology · 3,432 citations
https://doi.org/10.1037/h0027806
Donanemab in Early Symptomatic Alzheimer Disease
2023 · JAMA · 2,176 citations
https://doi.org/10.1001/jama.2023.13239
STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early‐onset fetal growth restriction
2019 · BJOG An International Journal of Obstetrics & Gynaecology · 86 citations
https://doi.org/10.1111/1471-0528.15658
Rapid anxiety assessment in medical patients: Evidence for the validity of verbal anxiety ratings
2000 · Annals of Behavioral Medicine · 64 citations
https://doi.org/10.1007/bf02895114
A descriptive analysis of pediatric post-tonsillectomy pain and recovery outcomes over a 10-day recovery period from 2 randomized, controlled trials
2020 · PAIN Reports · 30 citations
https://doi.org/10.1097/pr9.0000000000000819
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat